Results
21,218 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 | Riesterer Terry L.Vice President and Controller |  ROKROCKWELL AUTOMATION, INCOpen-market sale · 10b5-1 plan | SELL | $4,033 10 sh | Dec 5, 2025 traded Dec 5, 2025 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 | Riesterer Terry L.Vice President and Controller | ROKROCKWELL AUTOMATION, INC Open-market sale · 10b5-1 plan | SELL | $4,033 10 sh | Dec 5, 2025 traded Dec 5, 2025 | |
Li Jeffrey KSVP and Secretary |
 KEYSKeysight Technologies, Inc.Open-market sale · 10b5-1 plan |
| SELL |
| $790K 3,934 sh |
| Dec 5, 2025 traded Dec 3, 2025 |
| 20 | Mansharamani LeenaSVP, Chief Accounting Officer |  FIVNFive9, Inc.Open-market sale · 10b5-1 plan | SELL | $24K 1,187 sh | Dec 5, 2025 traded Dec 4, 2025 |
| 19 | Rasmussen KrisChief Technology Officer |  FIGFigma, Inc.Open-market sale · 10b5-1 plan | SELL | $592K 15.8K sh | Dec 5, 2025 traded Dec 3, 2025 |
| 19 | Allan JonathanGENERAL COUNSEL & CORP SEC |  STOKStoke Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $169K 5,437 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 19 | Robins Harlan SChief Scientific Officer |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $166K 10.0K sh | Dec 5, 2025 traded Dec 4, 2025 |
| 17 | Novack Jeffrey AdamSecretary and General Counsel |  CDNACareDx, Inc.Open-market sale | SELL | $5,648 286 sh | Dec 5, 2025 traded Dec 4, 2025 |
| 17 | Sylebra Capital LlcSee Footnote |  PIIMPINJ INCOpen-market sale | SELL | $221K 1,373 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 16 | Mulligan BrendanGeneral Counsel and Secretary | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $69K 1,900 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 16 | Mulligan BrendanGeneral Counsel and Secretary | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $92K 2,492 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 16 | Bulho Matheus De A G VieraSVP Software and Control | ROKROCKWELL AUTOMATION, INC Open-market sale · 10b5-1 plan | SELL | $8,877 22 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 16 | Voskanian ShauntChief Revenue Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $92K 2,560 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 16 | Hennessy Daniel JDirector |  INVInnventure, Inc.Open-market sale · 10b5-1 plan | SELL | $290K 55.8K sh | Dec 5, 2025 traded Dec 4, 2025 |
| 16 | Bulho Matheus De A G VieraSVP Software and Control | ROKROCKWELL AUTOMATION, INC Open-market sale · 10b5-1 plan | SELL | $38K 95 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 16 | Munshi SanjayChief Operating Officer |  NTCTNETSCOUT SYSTEMS INCOpen-market sale · 10b5-1 plan | SELL | $54K 2,000 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 16 | Dignan AndyPresident | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $14K 700 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 16 | Voskanian ShauntChief Revenue Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $139K 3,745 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 15 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $52K 1,673 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 15 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $62K 1,989 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 15 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $74K 2,344 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 15 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $42K 1,373 sh | Dec 5, 2025 traded Dec 4, 2025 |
| 15 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS |  TBPHTheravance Biopharma, Inc.Open-market sale · 10b5-1 plan | SELL | $291K 15.5K sh | Dec 5, 2025 traded Dec 3, 2025 |
| 14 | Campbell Lisa MDirector |  DTDynatrace, Inc.Open-market sale · 10b5-1 plan | SELL | $11K 253 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 13 | Herb TylerChief Accounting Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $43K 1,200 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 13 | Herb TylerChief Accounting Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 1,110 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 11 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $25K 824 sh | Dec 5, 2025 traded Dec 4, 2025 |
| 11 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $6,075 194 sh | Dec 5, 2025 traded Dec 4, 2025 |
| 11 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $10K 323 sh | Dec 5, 2025 traded Dec 4, 2025 |
| 9 | Gibson ChristopherDirector, Chief Executive Officer |  RXRXRECURSION PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $185K 40.0K sh | Dec 5, 2025 traded Dec 4, 2025 |
| 8 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | TBPHTheravance Biopharma, Inc. Open-market sale · 10b5-1 plan | SELL | $146K 7,766 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 8 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $31K 1,004 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 8 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | TBPHTheravance Biopharma, Inc. Open-market sale · 10b5-1 plan | SELL | $146K 7,767 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 8 | Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER |  OMCLOMNICELL, INC.Open-market sale · 10b5-1 plan | SELL | $244K 6,106 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 7 | Barrett David MichaelDirector, Chief Executive Officer |  EXFYExpensify, Inc.Open-market sale · 10b5-1 plan | SELL | $46K 30.0K sh | Dec 5, 2025 traded Dec 1, 2025 |
| 7 |  Dines DanielDirector, CEO and Chairman, 10% Owner |  PATHUiPath, Inc.Open-market sale · 10b5-1 plan | SELL | $819K 45.0K sh | Dec 5, 2025 traded Dec 5, 2025 |
| 48 | Sweeny NicoleChief Commercial Officer |  KALVKalVista Pharmaceuticals, Inc.Open-market sale | SELL | $51K 3,813 sh | Dec 4, 2025 traded Nov 24, 2025 |
| 45 | McBee BranninChief Development Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $194K 2,378 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 45 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 793 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 45 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $194K 2,378 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 45 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $82K 994 sh | Dec 4, 2025 traded Dec 2, 2025 |